Location of the first genetic locus, PKDr1, controlling autosomal dominant polycystic kidney disease in Han:SPRD cy/+ rat

被引:38
|
作者
Bihoreau, MT
Ceccherini, I
Browne, J
Kranzlin, B
Romeo, G
Lathrop, GM
James, MR
Gretz, N
机构
[1] IST GIANNINA GASLINI,GENET MOL LAB,I-16148 GENOA,ITALY
[2] UNIV HEIDELBERG,KLINIKUM MANNHEIM,MED RES CTR,D-68167 MANNHEIM,GERMANY
[3] INT AGCY RES CANC,GENET CANC SUSCEPTIBIL UNIT,F-69372 LYON,FRANCE
[4] UNIV HEIDELBERG,DEPT MED 4,KLINIKUM MANNHEIM,D-68167 MANNHEIM,GERMANY
基金
英国惠康基金;
关键词
D O I
10.1093/hmg/6.4.609
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Han:SPRD cy/+ strain develops a form of slowly progressive disease that appears similar in many respects to that seen in the autosomal dominant polycystic kidney disease (ADPKD) in humans. We have performed a total genome scan in an experimental backcross population derived from affected Han:SPRD cy/+ rat (PKD) and non-affected Wistar Ottawa Karlsburg rat (WOK) using 117 microsatellite markers. The genetic dissection of PKD allowed us to map on rat chromosome 5, a quantitative trait locus (QTL) controlling PKD, kidney mass and plasma urea concentration, The homology region is likely to reside on human chromosome 8, The gene responsible for PKD in Han:SPRD cy/+ rat is neither PKD1, localised on human chromosome 16, nor PKD2, localised on human chromosome 4. Therefore, we propose that this new locus be denoted PKDr1. The detection of the PKDr1 locus and associated QTL should accelerate research into the genetic causes of ADPKD.
引用
收藏
页码:609 / 613
页数:5
相关论文
共 50 条
  • [31] Genetic heterogeneity of autosomal dominant polycystic kidney disease in Argentina
    Iglesias, DM
    Martin, RS
    Fraga, A
    Virginillo, M
    Kornblihtt, AR
    Arrizurieta, E
    Viribay, M
    SanMillan, JL
    Herrera, M
    Bernath, V
    JOURNAL OF MEDICAL GENETICS, 1997, 34 (10) : 827 - 830
  • [32] Genetic Characteristics of Family Autosomal Dominant Polycystic Kidney Disease
    Liu, J.
    Liu, F. S.
    Wang, F.
    Zhao, W. N.
    Li, R.
    Liu, Z. T.
    Zou, H. M.
    Fan, G. H.
    Zhang, C. Q.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2019, 67 : S618 - S618
  • [33] Autosomal dominant polycystic kidney disease - Clinical and genetic aspects
    Bogdanova, N
    Markoff, A
    Horst, J
    KIDNEY & BLOOD PRESSURE RESEARCH, 2002, 25 (05): : 265 - 283
  • [34] Mutation analysis of autosomal dominant polycystic kidney disease genes in Han Chinese
    Zhang, SZ
    Mei, CL
    Zhang, DY
    Dai, B
    Tang, B
    Sun, TM
    Zhao, HD
    Zhou, YK
    Li, L
    Wu, YM
    Wang, WJ
    Shen, XF
    Song, J
    NEPHRON EXPERIMENTAL NEPHROLOGY, 2005, 100 (02): : 63 - 76
  • [35] POLYCYSTIC KIDNEY-DISEASE IN THE HANS - SPRD-CY RAT - AN OSMOREGULATORY METABOLIC DISORDER
    OGBORN, MR
    PRYCHITKO, J
    SAREEN, S
    PEELING, J
    PEDIATRIC RESEARCH, 1995, 37 (04) : A367 - A367
  • [36] AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY-DISEASE IN THE RAT
    COWLEY, BD
    GUDAPATY, S
    KRAYBILL, AL
    BARASH, BD
    HARDING, MA
    CALVET, JP
    GATTONE, VH
    KIDNEY INTERNATIONAL, 1993, 43 (03) : 522 - 534
  • [37] Global gene expression profiling in early-stage polycystic kidney disease in the Han:SPRD Cy rat identifies a role for RXR signaling
    Kugita, Masanori
    Nishii, Kazuhiro
    Morita, Miwa
    Yoshihara, Daisuke
    Kowa-Sugiyama, Hiroe
    Yamada, Kouji
    Yamaguchi, Tamio
    Wallace, Darren P.
    Calvet, James P.
    Kurahashi, Hiroki
    Nagao, Shizuko
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2011, 300 (01) : F177 - F188
  • [38] MAPPING THE LOCUS OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY-DISEASE - DIAGNOSTIC APPLICATION
    REEDERS, ST
    GERMINO, GG
    GILLESPIE, GAJ
    CLINICAL CHEMISTRY, 1989, 35 (7B) : B13 - B16
  • [39] Effects of lovastatin treatment on the metabolic distributions in the Han:SPRD rat model of polycystic kidney disease
    Jelena Klawitter
    Iram Zafar
    Jost Klawitter
    Alexander T Pennington
    Jacek Klepacki
    Berenice Y Gitomer
    Robert W Schrier
    Uwe Christians
    Charles L Edelstein
    BMC Nephrology, 14
  • [40] Effects of lovastatin treatment on the metabolic distributions in the Han:SPRD rat model of polycystic kidney disease
    Klawitter, Jelena
    Zafar, Iram
    Klawitter, Jost
    Pennington, Alexander T.
    Klepacki, Jacek
    Gitomer, Berenice Y.
    Schrier, Robert W.
    Christians, Uwe
    Edelstein, Charles L.
    BMC NEPHROLOGY, 2013, 14